Holdings of Lynx1 Capital Management LP
20 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 97.6 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 20 | 479.1M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Stoke Therapeutics Inc | 4,763,673 | 155.1M $ | |
| 2 | Cullinan Therapeutics Inc | 8,963,500 | 127.4M $ | |
| 3 | Agios Pharmaceuticals Inc | 2,611,568 | 88.3M $ | |
| 4 | Denali Therapeutics Inc | 1,880,303 | 36.1M $ | |
| 5 | C4 Therapeutics Inc | 6,998,902 | 18.4M $ | |
| 6 | Korro Bio Inc | 1,538,296 | 17.4M $ | |
| 7 | TScan Therapeutics Inc | 8,019,148 | 8.1M $ | |
| 8 | Xencor Inc | 536,398 | 6.5M $ | |
| 9 | Precision BioSciences Inc | 985,113 | 5.4M $ | |
| 10 | Passage Bio Inc | 623,704 | 4.9M $ | |
| 11 | NEUPHORIA THERAPEUTICS INC | 875,328 | 3.6M $ | |
| 12 | Entrada Therapeutics Inc | 211,689 | 2.7M $ | |
| 13 | CG oncology Inc | 31,591 | 2.1M $ | |
| 14 | Design Therapeutics Inc | 119,516 | 1.3M $ | |
| 15 | VYNE THERAPEUTICS INC | 1,628,700 | 973.1K $ | |
| 16 | WEREWOLF THERAPEUTICS INC | 657,786 | 547.7K $ | |
| 17 | IBIO INC | 68,076 | 129.3K $ | |
| 18 | BOLT BIOTHERAPEUTICS INC | 30,800 | 124.4K $ | |
| 19 | Absci Corp | 21,245 | 63.7K $ | |
| 20 | TRAWS PHARMA INC | 15,078 | 27.6K $ |